NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc. (Nasdaq: NRXP) is a clinical-stage biopharmaceutical company that entered the public markets through a business combination with Big Rock Partners Acquisition Corp, a blank-check vehicle sponsored by Big Rock Partners Management LLC that completed its initial public offering in 2018. Focused on developing therapies for central nervous system disorders and critical-care conditions, the company filed a Form 10-Q with the Securities and Exchange Commission on May 15, 2020, providing a quarterly update on its financial position and operational progress in the healthcare and biopharmaceutical sector. Investors and analysts seeking complete filing history, sponsor profiles, and deal analytics for NRXP can sign up for full data access at SpacDesk.